CD38 modulating antibody
NZ800125BActive Publication Date: 2026-09-01BLACK BELT THERAPEUTICS LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- NZ800125
- Authority / Receiving Office
- NZ · NZ
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-08-16
- Filing Date
- 2018-06-08
- Publication Date
- 2026-09-01
- Estimated Expiration
- 2038-06-08
Smart Images
Figure 00000143_0000 
Figure 00000145_0000 
Figure 00000145_0001
Abstract
The present disclosure provides antibodies that bind to human CD38. In particular, the antibodies and antigen-binding portions thereof are defined by particular functional characteristics. The antibodies present features compatible for manufacturing and can be provided as fully human antibodies (e.g., fully human monoclonal antibodies or antigen-binding fragments) that can be useful for medical methods and compositions, in particular for treating cancer.
Need to check novelty before this filing date? Find Prior Art